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Forty-seven Salmonella Typhimurium (33 zoonotic, 14
clinical) strains were tested for antimicrobial resistance
using the standard disk diffusion method. The presence of
relevant resistance genes and class 1 integrons were
investigated by using PCR. Pulsed-field gel electrophoresis
(PFGE) and plasmid profiling were carried out to determine
the genomic diversity of Salmonella Typhimurium.
Approximately 57.4% of the S. Typhimurium strains were
multidrug resistant (MDR) and showed high resistance rates
to tetracycline (70.2%), sulfonamides (57.4%), streptomycin
(53.1%), ampicillin (29.7%), nalidixic acid (27.6%), kanamycin
(23.4%), chloramphenicol (21.2%), and trimethoprim
(19.1%). Resistance towards cephalosporins was noted
for cephalothin (27.6%), cephradine (21.2%), amoxicillin
clavulanic acid (17.0%), and cephalexin (17.0%). Resistance
genes, bla
TEM
, strA, aadA, sul1, sul2, tetA, tetB, and tetC,
were detected among the drug-resistant strains. Thirty-
three strains (70.2%) carried class 1 integrons, which
were grouped in 9 different profiles. DNA sequencing
identified sat, aadA, pse-1, and dfrA genes in variable
regions on class 1 integrons. Thirty-five strains (74.4%)
were subtyped to 22 different plasmid profiles, each with
1-6 plasmids (2.0 to 95 kb). PFGE subtyped the 47 strains
into 39 profiles. In conclusion, high rates of multidrug
resistance were found among the Malaysian Salmonella
Typhimurium strains. The emergence of multidrug-resistant
Salmonella Typhimurium to cephalosporin antibiotics was
also observed. The strains were very diverse and no
persistent clone was observed. The emergence of MDR
Salmonella Typhimurium is a worldwide problem, and this
report provides information for the better understanding of
the prevalence and epidemiology of MDR S. Typhimurium
in Malaysia.
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Human salmonellosis continues to be a major public health
problem in both developed and developing countries.
Nontyphoidal salmonellosis (NTS), caused by salmonellae
other than Salmonella Typhi, is by far the most common
cause of bacteremia associated with gastroenteritis. Between
1973 and 1982, Salmonella Typhimurium was the most
common Salmonella isolated from patients attending the
University Hospital in Kuala Lumpur, Malaysia. Out of a
total of 969 strains isolated from blood and feces (excluding
S. Typhi), 155 (~16%) were Salmonella Typhimurium
(S.D. Puthucheary, personal communication). Salmonella
Typhimurium was also the most common NTS (10%)
isolated throughout Malaysia during the same decade [34]
but dropped to 4.06% from 1983 to 1992.
The occurrence of Salmonella Typhimurium phage type
104 (DT104) resistant to ampicillin, chloramphenicol,
streptomycin, sulfonamide, and tetracycline has been
reported worldwide [29]. The resistance of this serovar to
cephalosporins, due to the production of extended-spectrum
β-lactamase (ESBL), has also been reported [26]. Dissemination
of the antimicrobial resistance is often through mobile
genetic elements such as plasmids, transposons, and gene
cassettes in integrons [20]. Class 1 integrons are most
frequently found among clinical isolates that contain
antimicrobial resistance genes in the internal variable
region. This integron-containing antibiotic resistance gene
cluster has been found near the 3' end of Salmonella
genomic island 1 (SGI1) of serovar Typhimurium [8].
Phenotypic methods for identifying and typing of
Salmonella Typhimurium are serotyping, biotyping, and
phage typing, all showing limited discriminatory powers.
Plasmid profiling, ribotyping, IS200 typing, multilocus
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sequence typing (MLST), PCR-based methods, and pulsed-
field gel electrophoresis (PFGE) have recently proven to be
useful in discriminating strains of S. Typhimurium [13, 32].
There is a lack of information on S. Typhimurium in
Malaysia and this study was carried out to obtain better
strain discrimination of this serovar isolated between 1969
to 2006 from animals and humans through a combination
of methods. The detection and analysis of antibiotic
resistance genes and integrons were carried out by using
PCR and DNA sequencing, and the genetic relatedness
was determined by PFGE and plasmid fingerprinting.
MATERIALS AND METHODS
Bacterial Strains
Forty-seven Salmonella Typhimurium strains were studied. The
human strains (n=14) isolated from 1969 to 2006 were from a local
teaching hospital. The zoonotic strains (n=33) recovered from a
variety of animals (cattle, n=9; chicken, n=14; swine, n=1; fish,
n=1; frog, n=1) and unknown zoonotic hosts (n=7) were provided
by the Veterinary Research Institute, Malaysia. All the strains were
confirmed to be S. Typhimurium by standard biochemical and
serological tests at the Microbiology Laboratories of the Institutions
that processed the specimens. The purity of the strains was checked
by plating the cultures on selective media (XLD and BSA) at the
Biomedical Science Laboratory, IPS, University of Malaya, where
the analysis was carried out. 
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility testing was done using the disk diffusion
assay on Mueller-Hinton agar with commercial antibiotic disks
(Oxoid Ltd, Basingstoke, U.K.) according to the CLSI guidelines
[11]. Escherichia coli ATCC 25922 and Pseudomonas aeruginosa
ATCC 27853 were used as controls. The antimicrobials used were
nalidixic acid (10 µg), ampicillin (10 µg), streptomycin (10 µg),
ciprofloxacin (5µg), trimethoprim/sulfamethoxazole (25µg), tetracycline
(30 µg), chloramphenicol (30 µg), trimethoprim (5 µg), gentamicin
(30 µg), kanamycin (30 µg), sulfonamide (300 µg), amoxicillin/
clavulanic acid (30 µg), ceftiofur (30 µg), cefepime (30 µg), aztreonam
(30 µg), cephalothin (30 µg), ceftazidime (30 µg), cephradine (30 µg),
ceftriaxone (30 µg), cephalexin (30 µg), cefuroxime (30 µg), and
cefotaxime (30µg) (Becton Dickinson). Interpretation of inhibition zones
was according to CLSI guidelines [11]. Interpretations for ceftiofur,
which was not given in the CLSI guidelines, was as recommended
by the manufacturer.
DNA Template Preparation for PCR
One bacterial colony from Luria-Bertani (LB) plate was suspended
in 1.0 ml of phosphate-buffered saline (PBS), centrifuged, and the
cell pellet resuspended in 100 µl of TE buffer (10 mM Tris, 1 mM
EDTA buffer, pH 8.0) and boiled at 99
o
C for 10 min. For each PCR
reaction, 5 µl (~100 ng) of the supernatant was used.
Differentiation of Phage Type DT104
As phage typing facilities are not available in Malaysia, further
differentiation of S. Typhimurium to phage type DT104, a commonly
reported phage type associated with zoonotic strains, was performed
using a multiplex PCR. Published primers for confirmation of
Salmonella genus, Salmonella Typhimurium, and phage type DT104
are indicated in Table 1. PCR conditions consisted of an initial
denaturation at 95oC for 2 min, 30 cycles each of 95oC for 1 min,
57
o
C for 1 min, and 72
o
C for 2 min, and a final extension at 72
o
C
for 5 min [4].
Detection of Resistance Genes
PCR detection and confirmation of resistance to ampicillin,
streptomycin, sulfonamides, and tetracycline were carried out using
published primer sequences (Table 1). Initially, a monoplex-PCR
was used for each of the primer sets to determine its specificity and
reproducibility. Then, 3 multiplex-PCRs (mPCR) were optimized to
enable simultaneous amplification of multiple resistance genes.
mPCRI consisted of 4 primer pairs for bla
TEM
,
 
strA, sul1, and sul2.
mPCRII consisted of another 4 primer pairs for tetA, tetB, temB, and
aadA, whereas mPCRIII consisted of 3 primer pairs for temA, tetG,
and tetC. The conditions for mPCRI were an initial denaturation at
94oC for 3 min followed by 30 cycles of 94oC for 30 s, 53oC for
30 s, and 72
o
C for 1 min, with a single final extension at 72
o
C for
7 min. For mPCRII and mPCRIII, the annealing conditions were
changed to 62oC for 30 s. All mPCRs were performed in a 25-µl
reaction mixture containing 1× PCR buffer, 1.5 mM MgCl
2
, 200 µM
each of dNTPs, 60 pmol of each primer, 1 U of Taq DNA polymerase
(Intron, Biotechnology, South Korea), and 100 ng of template DNA.
The PCR products were analyzed by electrophoresis through a 1.5%
agarose gel (Promega, Madison, U.S.A), staining with ethidium
bromide (0.5 µg/ml), and then visualizing using the GelDoc (BioRad).
A DNA ladder of 100 bp (Promega) was used as the molecular
weight marker.
Detection of Integrons
Isolates were screened for the presence of class 1 integrons using
specific primers previously described [20] to anneal the 5' conserved
sequences (CS) and 3' CS flanking the integrated gene cassettes
(Table 1). PCR was performed in a 25-µl final volume containing
1× PCR buffer, 1.5 mM MgCl
2
, 200 µM each of dNTPs, 1 U Taq
DNA polymerase (Intron, Biotechhnology, South Korea), 25 pmol
of each primer, and 100 ng of template DNA. The cycling conditions
consisted of an initial denaturation at 94oC 10 min, 35 cycles each of
94
o
C for 1 min, 55
o
C for 1 min, and 72
o
C for 5 min, and further
extension at 72oC for 5 min [12]. The amplification reaction included a
negative control, which contained all reagents except target DNA. The
PCR products were analyzed by electrophoresis on 1% agarose gel.
DNA Sequencing
Selected amplified DNA products were verified by DNA sequencing.
The amplicons were purified using a DNA purification kit (Qiagen,
Germany) and sent to a commercial facility for sequencing (Research
Biolabs, Singapore). The ABI PRISM Big Dye terminator cycle
sequencing system was used (Perkin Elmer, Applied Biosystems).
The resulting DNA sequence data were compared with the GenBank
database using the BLAST algorithm available on the NCBI Web site
(http://www.ncbi.nih.gov).
Plasmid Profiling
Plasmid DNA was extracted using a Q1Aprep spin miniprep kit
(Qiagen, Germany) according to the manufacturer’s recommendation.
The plasmid DNA was analyzed through 0.8% horizontal agarose
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gel electrophoresis. E. coli 39R and E. coli V517 were used as
molecular weight markers. 
PFGE Analysis
PFGE was carried out according to a previous protocol [28]. DNA
was digested with 10 U of restriction enzyme Xba1 (5'-TCTAGA-3')
(Promega, Madison, WI, U.S.A.) at 37oC. The restriction fragments
were separated by electrophoresis in 0.5× TBE buffer, for 22 h at
14oC in a CHEF Mapper system (Bio-Rad, U.S.A.) using pulsed
times of 2.2 to 63.8 s. XbaI-digested S. Braenderup H9812 was used
as the DNA size marker. PFGE data were analyzed using Gel
Compar software (version 4, Applied Maths). The extent of variability
was determined by the Dice coefficient F, as previously described
[28]. Clustering was based on the unweighted pair group average
method (UPGMA) with a position tolerance of 0.10. 
RESULTS
PCR and Phage types
The multiplex PCR products consisted of a 204-bp fragment
of the ompC sequence that is specific for the Salmonella genus,
a 401-bp fragment of the specific sequence in Typhimurium,
and a 102-bp fragment of the specific sequence in DT104.
Out of the initial 59 S. Typhimurium isolates provided by
the collaborating centers, 47 were confirmed as serotype
Salmonella Typhimurium as indicated by the presence of
2 bands, 204 bp and 401 bp. The other 12 Salmonella
strains had only one amplicon, 204 bp. Among the 47 S.
Typhimurium strains, 20 were phage type DT104.
Antibiograms
Only 9 of the 47 confirmed S. Typhimurium strains were
susceptible to all the 22 antimicrobials tested, whereas 33
(70.2%) were resistant to more than one. All the animal
strains were susceptible to ciprofloxacin, cefuroxime,
ceftazidime, and aztreonam, whereas the human strains were
resistant to at least one antimicrobial agent (Table 2). High
rates of resistance to tetracycline (70.2%), sulfonamide
(57.4%), streptomycin (53.1%), ampicillin (29.7%), nalidixic
acid (27.6%), kanamycin (23.4%), chloramphenicol (21.2%),
and trimethoprim (19.1%) were observed for both human and
zoonotic strains (Table 2). Resistance towards cephalosporins
Table 1. Primers for detection of resistance genes and integrons in Salmonella via PCR.
Primers names Sequence (5'-3') Amplification target  Size (bp) Reference
OMPCF
OMPCR
ATCGCTGACTTATGCAATCG
CGGGTTGCGTTATAGGTCGT
Salmonella genus 204 [4]
104F
104R
ATGCGTTTGGTCTCAACGCC
GCTGAGGCCACGGATATTTA
S. Typhimurium
DT104
102
[4]
TyphF
TyphR
TTGTTCACTTTTTACCCCTGAA 
CCCTGACAGCCGTTAGATATT
S. Typhimurium 401 [4]
5'CS 3'CS
GGCATCCAAGCAGCAAG
AAGCAGACTTGACCTGA
Integron Variable  [20]
blaTem
ATGAGTATTCAACATTTCCG
ACCAATGCTTAATCAGTGAG
bla
TEM
859 [2]
StrA
 CCAATCGCAGATAGAAGGC
CTTGGTGATAACGGCAATTC
strA 548 [2]
Sul1
CTTCGATGAGAGCCGGCGGC
GCAAGGCGGAAACCCGCGCC
sul1 435 [2]
Sul2
GCGCTCAAGGCAGATGGCATT
GCGTTTGATACCGGCACCCGT
sul2 293 [2]
temA
ATGAGTATTCAACATTTCCG
CTGACAGTTACCAATGCTTA
temA 867 [23]
temB
TTTTCGTGTCGCCCTTATTCC
CGTTCATCCATAGTTGCCTGACTC
temB 79 [31]
TetA
GTAATTCTGAGCACTGTCGC
CTGCCTGGACAACATTGCTT
tetA 956 [2]
TetB
CTCAGTATTCCAAGCCTTTG
ACTCCCCTGAGCTTGAGGGG
tetB 414 [2]
TetC
GGTTGAAGGCTCTCAAGGGC
CCTCTTGCGGGAATCGTCC
tetC 505 [2]
TetG
GCAGCGAAAGCGTATTTGCG
TCCGAAAGCTGTCCAAGCAT
tetG 662 [2]
aadA
ATCCTTCGGCGCGATTTTG
GCAGCGCAATGACATTCTTG
aadA 282 [2]
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was as follows: cephalothin (27.6%), cephradine (21.2%),
amoxicillin (17.0%), and cephalexin (17.0%). Twenty-nine
resistotypes were defined (Table 3). The predominant resistotype
was P8 (simultaneous resistance to S, Su, T), followed by
resistotypes P3 and P7. The rest of the resistotypes were
represented by one strain each (Table 3).
Multidrug resistance (MDR), defined as resistance to 3
or more groups of antimicrobial agents, was detected in 27
(57.4%) strains (Table 3). Three common R-types were
observed: R-type ACSSuTe (n=8), R-type SSuTe (n=7),
and R-type KSSuTeTm (n=3) with or without additional
resistance to antimicrobial agents.
Detection of Resistance Genes
The simultaneous detection of different antimicrobial
resistance genes such as blaTEM, strA, aadA, sul1, sul2, tetA,
tetB, tetC, and tetG was carried out using three multiplex-
PCRs (Fig. 1). All the 14 (100%) ampicillin-resistant strains
harbored blaTEM, temA, and temB with sizes 859 bp, 867 bp,
and 798 bp, respectively. A comparison between sequenced
fragments of blaTEM-positive strains and available sequences
in the GenBank revealed similar identity (95%) with blaTEM.
All 25 streptomycin-resistant strains harbored the strA
gene, and only 14 (56.0%) harbored the aadA gene. Both
strA and aadA genes were present in 11 (44.0%) strains.
Ten of the 27 (37.0%) sulfonamide-resistant strains
harbored sul1, and 24 (88.8%) harbored sul2, whereas 7
(25.9%) strains had both sul1 and sul2. Of the 33
tetracycline-resistant strains, 23 (69.6%) contained the tetA
gene, 5 (15.1%) had tetB, and 4 (12.1%) had tetC. No
strain was positive for tetG. A combination of tetA+tetB
genes was found in one strain (STM DT104 6344/95). One
tetracycline-resistant clinical strain (STM 0287/69) did not
harbor any of the 4 tetracycline-resistant genes. 
Detection of Integrons
Class 1 integrons were present in 33 (70.2%) of the strains:
13 clinical and 20 zoonotic. Three strains carried one
integron, 19 strains carried 2, and 11 strains carried 3. All
except one integron-positive strain carried the 210-bp size
integron. Sequencing analysis showed that the 210-bp
fragment is a part of the purG gene that encodes the enzyme
phosphoribosylformylglycinamidine synthetase (GenBank
Accession No. AF151984). In the other profiles, 5 additional
amplicons were detected (650 bp, 800 bp, 1,000 bp, 1,200 bp,
1,900 bp). Integron 650 bp contained the sat gene that
encodes the enzyme streptothricin acetyltransferase and
confers resistance to streptothricin. Intergron 800 bp harbored
dfrA7 that encodes the enzyme dihydrofolate reductase
Table 2. Antimicrobial resistance among S. Typhimurium strains.
Antimicrobial agents
 Numbers (%) of resistant strains
Animal 
(n=33)
Human 
(n=14)
Total
Ampicillin 8 (24)  6 (43) 14 (30)
Chloramphenicol 5 (15) 5 (36) 10 (21)
Ciprofloxacin 0 (0) 1 (7) 1 (2)
Gentamicin 4 (12) 1 (7) 5 (11)
Kanamycin 5 (15) 6 (43) 11 (23)
Streptomycin 15 (45) 10 (71) 25 (53)
Nalidixic acid 12 (36) 1 (7) 13 (28)
Sulfonamides 16 (48) 11 (79) 27 (57)
Trimethoprim 5 (15) 4 (29) 9 (19)
Sxt 4 (12) 2 (14) 6 (15)
Tetracycline 21 (64) 12 (86) 33 (70)
Cephradine 5 (15) 5 (36) 10 (21)
Cephalexin 2 (6) 6 (43) 8 (17)
Ceftriaxone 1 (3) 1 (7) 2 (4)
Cefuroxime 0 (0) 1 (7) 1 (2)
Cephalothin 7 (21) 6 (43) 13 (28)
Ceftazidime 0 (0) 1 (75) 1 (2)
AMC 4 (12) 4 (29) 8 (17)
Cefepime 0 (0) 1 (7) 1 (2)
Cefotaxime 1 (3) 1 (7) 2 (5)
Aztreonam 0 (0) 1 (7) 1 (2)
Ceftiofur 0 (0) 1 (7) 1 (2)
Sxt, trimethoprim/sulfamethoxazole; AMC, amoxicillin-clavulanic acid.
Fig. 1. Representative gel of multiplex-PCR for detection of resistance genes. 
DNA bands are indicated by bla
TEM
 (859 bp), strA (548 bp), sul1 (435 bp), and sul2 (293 bp). Lanes 1-14: DNA size standard (100-bp ladder), positive
control, 2625/05, 1204/05, 110187/70, 3866/05, 3865/05, 3077/05, 5229/05, 2559/05, 32/05, 447/05, 447/05, negative control.
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Table 3. Phenotypic and genotypic characteristics of zoonotic and human S. Typhimurium strains.
Strain No. Source PTa Resistotypes (profiles) Resistance genes present Plasmid sizes (kb) Integrons (kb)
PFGE 
profiles
5553/04 Animalc nd $ N 90 N X26
2593/04 Cattle nd $ N 90 N X16
1377/05 Frog nd $ N 2.0, 28.9, 95 N X39
1621/05 Chicken nd $ N 90 N X8
2560/05 Chicken nd $ N 3.8, 2.6 N X30
2552/05 Cattle nd $ N 13, 34.3, 65.2 N X37
3000/05 Fish nd $ N 13, 34.3, 65.2 N X21
2553/05 Cattle 104b $ N N N X22
0504/69 Human 104 $ N 2.7 N X7
3215/03 Cattle 104 CE (P1) N N N X15
1234/04 Animal nd Su (P2) sul2 N 0.21, 0.6 X26
402/05 Chicken nd T (P3) tetA 90 0.21, 0.8 X17
2599/05 Animal 104 T (P3) tetA N N X25
28723/77 Human nd T (P3) tetB N 0.21 X6
3865/05 Chicken 104 A, Nx (P4) bla
TEM
N N X30
01/06 Human 104 CE, CL (P5) N N 0.21, 0.8 X19
7456/04 Cattle 104 Su, T (P6) sul2, tetA N 0.21, 0.6 X9
5067/05 Animal nd Nx, T (P7) tetA N 0.21, 0.6 X27
3503/05 Chicken nd Nx, T (P7) tetA N N X11
2555/05 Cattle 104 Nx, T (P7) tetA N N X10
8322/03 Chicken nd S, Su, T (P8) strA, sul2, tetA 11.3, 22.8, 50 0.21, 1.0 X28
6324/03 Chicken nd S, Su, T (P8) strA, sul2, tetA 11.3, 22.8, 50, 90 0.21, 1.0 X28
4524/05 Chicken nd S, Su, T (P8) strA, sul2, tetA 3.1, 11.3, 22.8, 50 0.21, 1.0 X31
0287/69 Human 104 S, Su, T (P8) strA, sul1, sul2 11.3, 22.8, 50 0.21, 1.0 X3
113254/70 Human 104 S, Su, T (P8) strA, sul2, tetA 2.6, 11.3, 22.8 0.21, 1.0 X1
32/05 Human nd S, Su, T (P8) strA, sul2, tetA 11.3, 22.8, 50 0.21, 1.0 X18
254/98 Chicken nd G, Nx, S, T (P9) strA, tetB 5.4 0.21, 1.0 X12
981/04 Animal nd Nx, S, Su,T (P10) strA, sul2, tetA 22.8, 50, 90 0.21, 1.0 X36
5231/05 Cattle 104 S, Su, T, CE (P11) strA, sul2, tetA N 0.21, 0.6 X21
3068/98 Chicken 104 A, G, N, S, T (P12) bla
TEM
, strA, temB, tetB, aadA 2.0, 2.2 0.21, 1.0 X32
5229/05 Chicken nd K, S, Su, T, Tm (P13) strA, sul2, tetA 11.3, 22.8, 50, 90 0.21, 0.6, 1.0 X27
447/05 Human 104 K, S, Su, Sxt, T, Tm (P14) strA, sul1, tetA, aadA 3.4, 4.3, 90 0.21, 1.9 X24
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Table 3. Continued.
Strain No. Source PTa Resistotypes (profiles) Resistance genes present Plasmid sizes (kb) Integrons (kb)
PFGE 
profiles
87098/70 Human 104 CE, CL, KF, S, Su, T (P15) strA, sul2, tetA , aadA 11.3, 22.8, 50, 90 0.21, 0.6, 1.0 X1
6344/95 Animal 104 C, CE, AMC, KF, S, Su, T (P16) strA, sul1, sul2, tetA, tetB, aadA 11.3, 22.8, 50, 90 0.21, 1.0, 1.2 X14
5532/04 Animal nd
A, N, Su, KF, CE, CL, 
AMC (P17)
bla
TEM
, sul2 2.0, 2.2 0.21, 0.6 X35
3866/05 Chicken nd A, Nx, S, Su, Sxt, T, Tm (P18) bla
TEM
, strA, sul1 tetA, temB, aadA, temA 2.2, 3.4 1.2, 1.9 X38
3077/05 Swine nd
K, S, Su, T, Tm, AMC, 
KF, CE (P19)
strA, sul2, tetA 10.6, 22.8 0.21, 0.6, 1.0 X34
95893/70 Human 104 A, C, S, Su, T, K, KF, CL (P20)
bla
TEM
, strA, sul1, sul2, temB, aadA, 
temA, tetC
2.6, 3.0, 7.5, 11.3, 32.1, 90 0.21, 1.0, 1.2 X5
79495/70 Human 104
A, C, S, Su, T, AMC, K, KF 
(P21)
bla
TEM
, sul1, sul2, temB, aadA, temA, 
tetC
34.3, 90 0.21, 1.0, 1.2 X1
30822/70 Human 104
A, C, K, Su, T, AMC, KF, 
CL (P22)
bla
TEM
, sul1, sul2, temB, aadA, temA, 
tetC
32.3, 90 0.21, 1.0 X2
3079/05 Cattle nd
A C, S, Su, T, K, Nx, Sxt, 
Tm, KF (P23)
bla
TEM
, strA, sul1, sul2, tetA, temB, 
aadA, temA
11.3, 22.8, 50, 90 0.21, 0.6, 1.9 X29
2559/05 Cattle nd
A, C, S, Su, T, Nx, Sxt, Tm, 
G, KF (P24)
bla
TEM
, strA, sul2, temB, aadA, tetB 4.9, 83.4, 90 0.21 X13
2625/05 Chicken nd
A, C, S, Su, T, K, Nx, Sxt, 
Tm, AMC, KF (P25)
bla
TEM
, strA, sul1, sul2, tetA, temB, 
aadA, temA
10.6, 28.3, 52.6 0.21, 0.6, 1.9 X20
110187/70 Human 104
A, C, S, Su, T, K, Tm, AMC, 
KF, CE, CL (P26)
bla
TEM
, strA, sul2, temB, aadA, temA 34.3, 90 0.21, 0.6, 1.0 X4
02/06 Human  nd
A, C, S, Su, T, Cip, G, K, Nx, 
Sxt, Tm (P27)
bla
TEM
, strA, sul1, tetA, temB, 
aadA, temA
2.6, 3.0, 7.5, 11.3, 22.8, 50 0.21, 0.6, 1.9 X23
1204/05 Chicken 104
A, C, S, Su, T, G, K, KF, 
AMC, CRO, CTX, CE, CL 
(P28)
bla
TEM
, strA, sul2, tetA, temA 3.4, 90 0.21 X33
196/05 Human nd
A, S, Su, T, XNL, KF, CL, 
CE, CXM, CRO, CTX, CAZ, 
AMC, FEP, ATM (P29)
bla
TEM
, strA, sul2, tetA, temB 3.4, 4.3, 11.3, 22.8, 50 0.21, 1.0, 1.2 X18
$, Sensitive; Nx, nalidixic acid; A, ampicillin; S, streptomycin; Cip, ciprofloxacin; Sxt, trimethoprim/sulfamethoxazole; T, tetracycline; C, chloramphenicol; Tm, trimethoprim; G, gentamicin; K,
kanamycin; Su, sulfonamides; XNL, ceftiofur; FEP, cefepime; ATM, aztreonam; KF, cephalothin; CAZ, ceftazidime; CE, cephradine; CRO, ceftriaxone; CL, cephalexin; CXM, cefuroxime; CTX,
cefotaxime; AMC, amoxicillin-clavulanic acid.
aPT, Phage Type; bPhage type DT104 determined by PCR; cUnknown animal hosts;  nd, not determined; N, no integron/gene/plasmid.
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and confers resistance to trimethoprim. Integron 1,000 bp
harbored the aadA2 gene that encodes for aminoglycoside
adenyltransferase AAD(3'') and confers resistance to
streptomycin-spectinomycin. Integron 1,200 bp harbored
the pse-1 gene that encodes for beta-lactamase and confers
resistance to ampicillin. Integron 1,900 bp harbored the
dfrA12 gene located near the 5' end that encodes for
dihydrofolate reductase and confers resistance to trimethoprim,
and the aadA2 gene located near the 3' end that encodes
aminoglycoside adenyltransferase AAD(3'') and confers
resistance to streptomycin-spectinomycin.
Plasmid Analysis
Thirty-five (74.4%) strains (12 human, 23 animal) harbored
1-6 plasmids (2.0 to 95 kb) each (Table 3). Two human
strains (STM 02/06 and STM 95893/70) had 6 plasmids
(Table 3). The predominant plasmid was 90 kb, present in
17 (48.5%) strains, followed by 22.8 kb (n=14), 11.3 kb
(n=13), and 50 kb (n=12).
Genotyping
PFGE of XbaI-digested chromosomal DNA subtyped all
the 47 strains into 39 pulsotypes (PFPs) with DNA fragments
Fig. 2. PFGE profiles of selected human and zoonotic S. Typhimurium strains.
A. Representative XbaI-PFGE profiles of selected human S. Typhimurium strains. Lanes 1, 7, 12, 18: Salmonella H9812 marker strain; lanes 2-6, 8-11,
13-17: 95893/70, 110187/70, 13254/70, 0504/69, 0287/69, 30822/70, 28723/77, 87098/70, 79495/70, 32/05, 196/0, 447/05, 01/06, 02/06. B. Representative
XbaI-PFGE profiles of selected zoonotic S. Typhimurium strains. Lanes 1, 5, 10, 14, 19: Salmonella H9812 DNA marker strain; lanes 2-4, 6-9, 11-13, 15-
18: 6321/03, 981/04, 5532/04,1234/04, 3079/05, 3503/05, 3866/05, 5553/04, 2593/04, 5231/05, 2560/05, 2553/05, 3000/05, 3865/05.
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ranging from 11 to 19 with sizes from 20.5 kb to 1,135 kb.
Wide genetic diversity was found among the strains (F=
0.4 to 1.0). Among these 39 different pulsotypes, 6 were
represented by 2 strains each. Three human strains of
phage type DT104 isolated in 1970 were indistinguishable
(Profile X1). The rest of the PFGE profiles were unique.
Among the 14 human strains, there were 11 PFPs (Fig. 2A),
whereas the 33 zoonotic strains had 28 PFPs (Fig. 2B).
Cluster analysis of the pulsotypes of the 47 S. Typhimurium
strains based on 70% similarity generated 2 major clusters,
Fig. 3. Dendrogram of cluster analysis of S. Typhimurium strains generated by Gel Compar software using the unweighted pair group
arithmetic means (UPGMA) methods. n=not determined.
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I and II (Fig. 3). Cluster I consisted of 10 strains (8 MDR,
1 drug-sensitive human strain, and 1 drug-sensitive zoonotic
strain). Cluster II consisted of 21 strains, comprising 16
PFPs divided into 2 subclusters, IIa and IIb. Subcluster IIa
consisted of 4 animal strains isolated between 1995 and
2005, each having a unique PFP, 3 MDR, and 1 drug-
sensitive strains. Subcluster IIb consisted of 17 strains,
comprising 12 PFPs. The rest of the 15 PFPs were not
included in any distinctive cluster, and each unique profile
was represented by 1 strain, except PFP X30, which was
represented by 2 strains. The majority of “older” human
strains isolated from 1969 to 1977 were grouped in cluster
I with similarity >85%, which suggests that they were very
closely related and were distinctly different from those
isolated in recent years. 
DISCUSSION 
In Malaysia, there is little information on the prevalence
of Salmonella Typhimurium. Although the number of
Salmonella infections caused by S. Typhimurium remains
relatively low, it is still important because of increasing
isolation of this particular serovar from food and animals
in Malaysia (unpublished data). 
Phage typing is important for the epidemiology of
Salmonella and has been used to describe pandemic clones
of S. Typhimurium DT104. In Malaysia, there are no
phage typing facilities for S. Typhimurium, and therefore
this is the first report from this region on the differentiation
of S. Typhimurium by PFGE and PCR. The use of PCR to
serotype S. Typhimurium has been successfully reported
by others [4].
A high level of multidrug resistance was found among
the 47 zoonotic and human strains of S. Typhimurium,
57.4% being resistant to 3 or more groups of antimicrobial
agents. The most common pattern shared among the strains
was ACSSuT. In this study, only 4 S. Typhimurium DT104
had this pattern.
High rates of resistance to tetracycline (70.2%) were
found among the strains. This finding was lower than those
from Korea where 90.0% of the S. Typhimurium animal
strains were resistant to tetracycline [33], probably due to
this agent being widely used in animal feed as a growth
enhancer [9]. High levels of resistance to streptomycin
(53%) and ampicillin (29.7%) were also found, but these
were lower than those from Taiwan, where 82% and 76%
of 242 strains were resistant to streptomycin and ampicillin,
respectively [19].
We found 57% of the strains were resistant to sulfonamides,
being similar to that reported by Lailler et al. [18], where
56% of 168 S. Typhimurium strains from cattle, pigs, and
poultry were resistant to sulfonamides. In addition, we also
observed 27.6% resistance to nalidixic acid and 19% to
trimethoprim. Numerous studies have reported the increase in
resistance of S. Typhimurium strains to nalidixic acid and
trimethoprim [6, 17], probably as a result of the use of
these agents in the treatment of invasive gastrointestinal
infections [1] and in animal feeds [30]. Besides the high
resistance to nalidixic acid, resistance to ciprofloxacin was
found in one human strain isolated in 2006. 
Resistance rates of S. Typhimurium strains to cephalosporins
were higher in the human than in the zoonotic strains,
probably due to the use of cephalosporin antibiotics in the
treatment of salmonellosis [10]. 
A multiplex-PCR was applied for accurate detection of
antibiotics resistance genes. Our results show that the
predominant tetracycline-resistant gene tetA was present in
both human and zoonotic strains, followed by tetB and tetC
genes. None of our tetracycline-resistant strains harbored
the tetG gene. However, Ng et al. [22] found that among
31 S. Typhimurium strains isolated in Canada, tetG was the
predominant tetracycline resistance gene present, followed
by tetB. 
Sulfonamide-resistant gene sul2 was detected among
our 27 sulfonamide-resistant strains. The sul2 gene has
been found associated with plasmids and not with the class
1 integron [5], but in our study the sul2 gene was found
alone in 17 integron-positive strains. The sul1 gene was
detected as part of the class 1 integron in 10 Malaysian
strains. Seven strains harbored both sul1 and sul2 genes,
indicating that these strains probably carried class 1 integrons
and plasmids.
The aadA gene, which confers resistance to streptomycin-
spectinomycin, was found as part of the class 1 integron,
in agreement with previous studies that it is present in
the variable region of class 1 integrons in S. Typhimurium
[6, 25].
The strA gene was the most frequently found in all
streptomycin-resistant strains, and has been reported to be
associated with plasmids [25]. Both strA and aadA genes
were present in 11 strains, which most probably carried
plasmids containing the strA gene and the class 1 integron
harboring the aadA gene.
Class 1 integrons were present in 33 (70.2%) strains,
indicating a wide distribution of this mobile genetic
element among the Malaysian Salmonella Typhimurium
strains. Most of the integron-positive strains carried the
210-bp integron, which appears to be unique for S.
Typhimurium [12] and is part of the purG gene. The
800-bp integron harbored dfrA7. Sequence analysis of the
1,000-bp amplicon of different integron profiles showed
the presence of aadA2 genes. The persistence and spread
of these genes in different Salmonella serotypes might be
associated with the extensive use of streptomycin in food
animals. Similar results were reported previously [6, 14].
The 1,200-bp region carried the pse-1 gene (AF153200).
Similar integrons were reported in several previous studies
[6, 22]. According to Guerra et al. [14], the presence of
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integrons with variable regions of 1,000 bp (aadA2) and
1,200 bp (pse-1) is very common among multiple resistant
DT104 strains. The 1,900-bp amplicon was found in multidrug-
resistant strains (resistant to more than 5 antimicrobial
agents), and sequencing analysis showed that the 1,900-bp
amplicon carried 2 genes; the dfrA12 gene, which conferred
resistance to trimethoprim, and the aadA2 gene, which
conferred resistance to streptomycin-spectinomycin. Guerra
et al. [15] also reported both these genes (aadA2 and
dfrA12) in the 1,900-bp class 1 integron in Salmonella
enterica serotype [4,5,12:i:-] isolated in Spain. Whether
the gene cassettes in the integrons are associated with
Salmonella Genomic Island I as commonly reported [8]
will be determined in future work.
Salmonellae can harbor plasmids of different molecular
sizes, ranging from 1 to 200 kb [27]. In this study, 22
different plasmid profiles with plasmids ranging from 2.0
to 95 kb were obtained. Ten small plasmids, 2.0, 2.2, 2.64,
3.1, 3.4, 3.8, 4.3, 5.4, 10.6, and 11.3 kb, were identified.
Similar small plasmid sizes were reported by Biendo et al.
[7] in France and Foley et al. [13] in the U.S.A.
Seventeen (48.5%) plasmid-positive strains harbored
the 90-kb plasmid, whereas one strain had the 95-kb
plasmid. This particular sized plasmid has been called the
Salmonella serovar-specific plasmid, and was reported in
several studies [3, 21].
No plasmid was detected in 11 drug-resistant S.
Typhimurium strains in this study. However, the gain or
loss of plasmids is well established, and therefore the
analysis of the plasmid profile is not a definitive typing
method. During plasmid extraction, shearing of large-
plasmid DNA and coprecipitation with the chromosomal
DNA are usually reported as one of the causes of plasmid
loss [16]. According to Olsen et al. [24], the absence of
plasmid in the resistant strains could be due to plasmid
instability, a common phenomenon among salmonellae. 
No distinct association was found between the resistant
phenotypes and XbaI-pulsotypes by cluster analysis of the
47 S. Typhimurium strains. PFGE did not distinguish the
drug sensitive and resistant strains, as they shared similar
pulsotypes. The human strains isolated between 1969 and
1977 were grouped in one cluster. All except one (28723/
77) were DT104, indicating that this phage type was
prominent in the S. Typhimurium population at that period
(1969-1977). These strains were very similar (85%), and
were closely related. We identified 22 unique PFGE
patterns among the zoonotic S. Typhimurium over a period
of 10 years (1995-2005). The high diversity of PFGE
subtypes suggests that the infections in different animal
hosts were from various sources. The majority of older
human strains isolated from 1969 to 1977 were grouped in
cluster I with similarity >85%, which suggests that they
were very closely related and were distinctly different
from those isolated in recent years.
In conclusion, high rates of resistance were found
among the strains indicated by the prevalence of resistance
genes. Approximately 70.2% and 74.4% of the strains
carried class 1 integrons and plasmids, which may explain
the dissemination of antimicrobial resistance genes through
these elements. The existence of multidrug-resistant S.
Typhimurium to cephalosporins was also observed. PFGE
analysis showed that the strains were very diverse and
no genotype seemed to predominate and persist over the
years. 
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